ReviewCurrent opinion in urology2020
The role of imaging in the diagnosis and management of Peyronie's disease.
Review in Current opinion in urology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed, 1 synthesis or guideline pooled it, 29 citations in OpenAlex.
- The Immunological Microenvironment and the Emerging Role of Stem Cells Therapy in Peyronie's Disease: A Systematic Narrative Review.International journal of molecular sciences · 2023Pooled it
- MRI of the Scrotum and Penis: Current Applications and Clinical Relevance.Diagnostics (Basel, Switzerland) · 2025Review
- Review
- Current and Future Directions of Technology in Assessment of Peyronie's Disease.Current urology reports · 2024Review
- The prevalence and topographic distribution of penile calcification in a large cohort: a retrospective cross-sectional study.International journal of impotence research · 2024Article
- Ultrasound Elastography as a Diagnostic Tool for Peyronie's Disease: A State-of-the-Art Review.Diagnostics (Basel, Switzerland) · 2024Review
- Disappearance of Plaque Following Treatment with Antioxidants in Peyronie's Disease Patients-A Report of 3 Cases.Clinics and practice · 2022Article
- Patients with Peyronie's disease achieve complete plaque regression after multimodal treatment with antioxidants: a case series.Journal of medical case reports · 2022Article
- Full Regression of Peyronie's Disease Plaque Following Combined Antioxidant Treatment: A Three-Case Report.Antioxidants (Basel, Switzerland) · 2022Article
- Use of penile shear wave elastosonography for the diagnosis of Peyronie's Disease: a prospective case-control study.Basic and clinical andrology · 2022Article
- Calcified Peyronie's Disease Frequency on Computed Tomography.Turkish journal of urology · 2022Article
- Complete Plaque Regression in Patients with Peyronie's Disease After Multimodal Treatment with Antioxidants: A Report of 2 Cases.The American journal of case reports · 2022Article
- The use of ultrasonography in the evaluation and management of peyronie's disease.Urology video journal · 2020Article
Corrections and comments
- Commented on by
Authors and funding
3 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purpose of reviewSeveral imaging modalities exist for the assessment of Peyronie's disease. However, comprehensive recommendations for using these objective modalities based on large-scale evidence-based studies do not yet exist. Our objective is to evaluate current imaging techniques and provide a model that we follow in our clinic in the workup and management of Peyronie's disease. RECENT
findingsComputed tomography and radiography excellently visualize penile plaque calcifications, and MRI adeptly identifies plaques in complex locations, such as the corporal septum. Ultrasonography has extensive applications in plaque localization and characterization. Used along with color Doppler ultrasound, it is capable of detecting vascular abnormalities. Sonoelastography is an emerging subtype of ultrasongraphy that utilizes elastic properties of tissue to identify penile plaques that may not be visualized with other modalities. SUMMARY: Ultrasonography is the preferred imaging modality in Peyronie's disease and noninvasively characterizes penile plaques and monitors plaque response to various treatments. At our center, we perform ultrasonography with intracavernosal injection in all patients with Peyronie's disease to evaluate the degree of curvature, plaque characteristics, and concomitant erectile dysfunction to better guide management decisions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.